This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BD Announces Chief Financial Officer Transition

FRANKLIN LAKES, N.J., Oct. 10, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that David V. Elkins, 44, Executive Vice President and Chief Financial Officer, has informed the Company of his plans to pursue an entrepreneurial opportunity at Round Rock Research, LLC, a technology licensing company, serving as its CFO.  He will leave BD in November following the Company's release of full fiscal year 2012 results on November 7, 2012.  BD's Board of Directors intends to commence a search for a successor to Mr. Elkins. 

Suketu Upadhyay, currently Senior Vice President and Controller, has been named as interim Chief Financial Officer, effective November 9, 2012.  Prior to his current role, Mr. Upadhyay served as the chief financial officer for BD's international operations.  Before joining BD in 2010, he held senior-level finance positions with Johnson & Johnson and AstraZeneca. 

Vincent A. Forlenza, Chairman, Chief Executive Officer and President, said, "I am genuinely disappointed that we are losing David.  He has been an outstanding chief financial officer and terrific partner since he joined BD in 2008, but we respect his decision to pursue the next chapter of his career elsewhere.  The Board and I are grateful for his contributions to BD and for his commitment to helping achieve a smooth transition. We wish him the best for the future."

Forlenza continued, "We are pleased that Suky has agreed to become interim CFO.  He has worked closely with David and me since joining the Company in 2010, and I am confident that BD will have a smooth transition. I am optimistic about the year ahead and look forward to updating investors and providing 2013 guidance on our November earnings call."  

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs